LIST OF POSTERS SELECTED IN PHARMACOGENOMICS AND CANCER (43)
On the date of June 27th (list open)
Abbasoglu Duygu
Eskişehir , Turkey
The Factors Affecting UGT1A1 Enzyme Activity of Irinotecan Drug
Response in Turkish Population
Aberkane Meriem
Oran Algeria
Genetic Polymorphisms in UDP-Glucuronosyl Transferase 1A1 and the
Risk for Colorectal Cancer in West Algerian population.
Adam de Beaumais
Tiphaine
PARIS, France
Is there an association between Glutamate Receptor Ionotropic, AMPA
subunit 1 variant (rs5849351) and clinical allergy to asparaginase in
childhood acute lymphoblastic leukemia?
Amirfallah Arsalan
Izmir, Turkey
Pharmacogenomics in Personalizing Fluorpyrimidine Based Therapy
Belaaloui Ghania
Batna, Algeria
Epigenetics, aging and cancer
Blein Sophie
Lyon, France
An original phylogenetic approach identified mitochondrial haplogroup
T1a1 as inversely associated with breast cancer risk in BRCA2 mutation
carriers
Bermudez-Bosch Luis
San Juan, Puerto Rico
A proposal for an individualized pharmacogenetic-guided warfarin
dosage regimen for Puerto Rican patients commencing anticoagulation
therapy.
Chatziliadi Constantina
Athens, Greece
Inicdence of single nucleotide polymorphism Rs9923231 in the VKORC1
gene, Rs1799853 and Rs1057910 in the CYP2C9 gene assiociated with
warfarin, on a 614 Greek volunteer sample
Doronina Svetlana
Borovliani, Belarus
Development of patient-specific idiotype DNA-vaccines for lymphoma
Elens Laure
Louvain, Belgium
González-Callejas
Desirée
Granada, Spain
Genetic predispositions to bad opioid response in preterm infants:
Impact of KCNJ6 and COMT polymorphisms on opioid effectiveness after
endotracheal intubation
Gene polymorphisms and opioid requirements in oncological pain
Hizel Candan
Eskişehir, Turkey
The perceptions of pharmacists on pharmacogenetics and its application
in Turkey compared to Greece, Italy, and Germany: A survey study.
Hoosain Nisreen
Cape Town, South
Africa
Genetic polymorphisms and haplotype structure of the organic cation
transporter 1 gene in the Zulu population of South Africa
Hoosain Nisreen
Cape Town, South
Africa
Genetic polymorphisms and haplotypes of the human organic cation
transporter 2 gene in the Zulu population
Hubacek Jaroslav
Prague, Czech Rep
Association between marker at chromosome 2 and acute coronary
syndrome is modified by statins.
Hubacek Jaroslav
Prague, Czech Rep
No effect of the polymorphism within the RYR2 transporter on
development of statin associated myalgia/myopathy in Czech population
Jimenez Enrique
Granada, Spain
Extrapolation of pharmacogenetic algorithms for acenocoumarol dosage
in different populations
Kushlinskii Nikolay
Moscow, Russia
Clinical prospects of metastatic, proliferative and angiogenic activity
markers study in ovarian cancer patients
Lamy Pierre-Jean
Montpellier, France
Prostate Health Index and PCA3 values for early diagnosis of prostate
cancer
Lima Áurea
Gandra, Portugal
Role of key TYMS polymorphisms on Methotrexate therapeutic outcome
in Rheumatoid Arthritis Portuguese patients
Lima Áurea
Gandra, Portugal
Liu Jeremy
Toronto, Canada
Prediction of Methotrexate Therapeutic Outcome in Rheumatoid
Arthritis Portuguese patients: Candidate Genes encoding Methotrexate
Membrane Transport Proteins
Performance of the Luminex® xTAG® CYP2C19 Kit v3 (EU)
Llerena Adrian
Badajoz, Spain
Allele frequencies of antiepileptic drug transporter genetic
polymorphisms in Mexican Mestizo population
Llerena Adrian
Badajoz, Spain
Lack of association between ABCC2 polymorphisms and carbamazepine neurological adverse drug reactions nor -response in Mexican Mestizo
patients
Llerena Adrian
Badajoz, Spain
Association of Km and vmax values of phenytoin with CYP2C9 and
CYP2C19 genotypes in Mexican Mestizo patients
Madrid Paredes Adela
Granada, Spain
IL28B Genotyping in the Setting of Telaprevir and Boceprevir Therapy
Maksimenko Andrei
Chatenay-Malabry,
France
Squalenoyl doxorubicin nanoassemblies: a unique ?spaghetti-like?
anticancer nanomedicine
Maksimenko Andrei
Chatenay-Malabry,
France
Viseu, Portugal
Therapeutic Modalities of Squalenoyl Nanocomposites in Colon Cancer
Nzabonimpa Grace
Shema
Lyngby, Denmark
A step towards personalized therapy of human carboxylesterase 1mediated drugs
Pérez Ramírez Cristina
Granada, Spain
Progression free survival in patients treated with Erlotinib as first,
second or third line therapy in advanced non-small cell lung cancer
analysed for EGFR status
Pilipenko Natalia
Moscow, Russia
Prevalence of cytochrome P-450 2C19 gene polymorphisms in Russian
patients with acid-related diseases
Puerta-Garcia Elena
Granada, Spain
NAT2 polymorphisms influence on taxanes toxicity
Resnier Pauline
Angers, France
Evaluation of active targeting strategies and siRNA delivery by lipid
nanocapsules on vitro and vivo melanoma model
Rieger Jessica K.
Stuttgart, Germany
MicroRNAs Associated with Pathophysiological Conditions in Liver and
their Effects on Drug Metabolism
Marques Ana
Margarida
DNA repair polymorphisms and oral cancer risk ? A systematic review.
Salazar Juliana
Barcelona, Spain
Genetic variants in methotrexate transporter genes as pharmacogenetic
markers in rheumatoid arthritis patients
Schneider Marion
Ulm, Germany
Large scale whole-blood phenotyping and plasma biomarker approach
to predict remisssion vs relapse in end-stage solid tumor patients
treated by regional chemotherapy
Stathopoulou Maria
Nancy, France
Genetic-determined Low Response to Thienopyridines is Associated with
Higher Systemic Inflammation in Smokers
Stsiohantsava Maryia
Borovlyany, Belarus
Molecular genetic analysis of CEBPA gene mutation status in normal
karyotype pediatric acute myeloid leukemia
Sukasem Chonlophat
Bangkok, Thailand
Teixeira Ana Luísa
Porto, Portugal
UGT1A1 polymorphisms and Irinotecan toxicity in Thai colorectal
cancers
Synergistic influence of EGF+61G>A and TGFB+869T>C polymorphisms in
renal cell carcinoma progression and overall survival: the link to plasma
circulating microRNAs
Yim Sung-Vin
Seoul Rep of Korea
Genetic polymorphisms affecting pharmacokinetics characteristics of
simvastatin
Yulia Marizina
Obninsk, Russia
Elevation of serum levels of soluble forms of stress-induced molecules
MICA in patients with a gastrointestinal cancer